Loading...
NPI 1720742752 · Coral Springs, FL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
True Labs LLC is a clinical medical laboratory provider located in Coral Springs, Florida. This profile covers 1 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | True Labs LLC |
| Address | 9315 W Sample Rd |
| City | Coral Springs |
| State | FL |
| ZIP | 33065 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | October 26, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $7.1M |
| Medicaid | $2.3K |
TRUE LABS LLC’s Medicare billing is overwhelmingly concentrated in a single service line: the top Medicare CPT/HCPCS codes by revenue are 100.0% of its total Medicare revenue, with K1034 listed as the primary revenue driver. The code description (provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count) indicates the operation is focused on high-volume provision or distribution of over-the-counter COVID-19 self-test kits rather than broad-spectrum clinical laboratory testing.
Financial scale and payer mix are highly skewed toward Medicare: lifetime Medicare revenue is reported as $7.1M while lifetime Medicaid revenue is $2.3K, meaning Medicare accounts for virtually all reported public-payer dollars. The provider is effectively single-payer in scale on the public programs, with Medicaid representing a negligible share of reported revenue.
Medicare volume economics show very high unit volume at low per-item reimbursement: K1034 has 601.2K claims at $12 avg paid/claim producing $7.2M revenue, which aligns with the top-code concentration noted above. This pattern — very large claim counts paired with low per-claim payment — is consistent with a fulfillment/distribution model for inexpensive, self-administered tests rather than a fee-for-service diagnostic lab mix.
Competitive standing for Medicare is extreme: K1034 ranks #68 of 30143 providers nationally and is labeled an "extreme outlier, far above typical national volume for this code," indicating TRUE LABS is a national-scale outlier for this specific commodity test. For payers and competitors analyzing market share, this provider should be considered a dominant national participant for K1034 activity.
By contrast, the provider’s Medicaid footprint is modest and not distinguishing: K1034 on the Medicaid side shows 3.5K claims at $1 avg paid/claim for $3.5K revenue, and the code ranks #8 of 238 in-state (97th percentile) while being described as "typical, unremarkable volume for this code." Despite a relatively high in-state rank, the absolute Medicaid revenue ($2.3K lifetime) and low per-claim payments imply limited Medicaid market impact.
Tenure is relatively recent: the provider’s NPI was enumerated on 2021-10-26 (~5 years ago), which coincides with the COVID-19 pandemic period and supports the plausibility of a business model centered on pandemic-era OTC test distribution. This timing is consistent with rapid scale-up in a narrow product line rather than a long-established, diversified clinical lab practice.
Revenue concentration creates operational dependency and strategic risk: with the top 3 Medicare codes accounting for 100.0% of Medicare revenue and the top 3 Medicaid codes accounting for 100.0% of Medicaid revenue, TRUE LABS has virtually no documented revenue diversification across payers. Any changes to reimbursement, coding, or demand for K1034-type tests would likely have an outsized effect on the provider’s public-payer revenue.
For competitive and utilization analysis, note the contrast in scale and characterization across payers: nationally, the provider is an "extreme outlier" for K1034 under Medicare, but its Medicaid activity for the same code is characterized as "typical, unremarkable" despite a high in-state rank. Analysts should therefore treat Medicare-derived insights as indicative of national high-volume dispensing operations while treating Medicaid figures as minimal and not representative of broader market dominance.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 601,160 | $10 | $7.2M |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
1 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| K1034 | 5 | 2,890 | 600 | $10 | $68.5K |
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 3,480 | $1 | $3.5K |
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 8 | 240 | 60 | $1 | $330 |
Other providers in the same ZIP code as True Labs LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.